Silver Book Fact

The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.

Cutler D, Long G, Berndt E, Royer J, et al. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler D, Long G, Berndt E, Royer J, et al.
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib related rates of hospital stays highest in adults ages 85+
    The rate of hospital stays involving atrial fibrillation in 2014 was more than three times as high among adults ages 85 years and older, compared with adults ages 65-84 (16,830…  
  • Projected AFib incidence, 2050
    If current incidence estimates are applied to Census Bureau projections, by 2050 the number of Americans with atrial fibrillation could exceed 12 million. If increases in incidence continue, that number could…  
  • 21% of American men and 24% of women age 40 years of age or older died 1 year after their first stroke in 2005.  
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Atrial fibrillation as a contributory cause of death, 2011
    Atrial fibrillation is a contributory cause of death for around 93,000 Americans each year.